Insurers are uncertain over the fate of cost-sharing reduction subsidies and that is expected to be reflected in prices next year. » Read More
By: Kayla Tausche
Uncertainty over the cost-sharing subsidies have led to higher price hikes for Obamacare plans next year in some states already. » Read More
By: Dylan Scott
If conservatives can't change Obamacare's insurance rules, it could put the whole repeal-and-replace effort in jeopardy, Vox reports. » Read More
By: Leslie Shaffer
Trump’s budget proposal will include massive cuts to Medicaid and other anti-poverty programs, the Washington Post reported, citing sources. » Read More
Finishing a marathon in under two hours is a holy grail for runners. A team of scientists explains how it can happen.
Republicans will introduce their much-awaited bill to repeal and replace the Affordable Care Act this week, a House Republican aide told NBC News.
Ava is an ovulation tracking bracelet worn at night when the woman is sleeping to track her most fertile days.
South Korea's Samsung Bioepis has won a high-stakes court case against U.S. drug firm AbbVie.
Republicans previously have promised quick action on gutting and replacing the Affordable Care Act.
Mylan was criticized last year after hiking EpiPen prices to $600, but has seen its stock surge after Donald Trump's election.
Republican efforts to repeal and replace Obamacare are being hampered by divisions within the GOP caucus over financial aid to customers.
People are dumping trendy protein powder into cups of joe for these natural health benefits, Mic reports.
The HPV vaccine is increasingly becoming the primary test for reducing cervical cancer deaths, STAT News reports.
An Obamacare repeal could promote 'job lock,' or staying at a job to get health insurance, New York Times reports.
Mylan CEO Heather Bresch shares her views on the pharmaceutical industry in an interview Friday on CNBC's "Power Lunch."
Republican Congressional leaders face pressure from conservatives to fully repeal Obamacare.
The number of American adults living with some form of hearing loss is expected to nearly double by 2060.
The drug, known as JCAR015, was being tested in adults with relapsed acute lymphoblastic leukemia, a rare and deadly blood cancer.
President Donald Trump told Congress that more needs to be done to bring down "artificially high" prices for drugs, while at the same time praising a drug that turns out to cost $300,000 per year.
Jim Cramer explained why investors should give the fast-growing tech companies the benefit of the doubt.
Jim Cramer went off the charts with Bob Lang to determine if pharma has more room to run.
Republicans considering proposals for repealing and replacing Obamacare face concerns over fewer people being covered.
Trump outlined his plan for an Obamacare replacement. The problem is, it doesn't match any of the GOP plans, says PolicyGenius CEO Jennifer Fitzgerald.
Here's a guide to the specific policies Trump mentioned, what they mean, and how they fit into the current political debate over the Affordable Care Act.
Get the best of CNBC in your inbox